Society guideline links: Neuropathy

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Neuropathic pain" and "Society guideline links: Radiculopathy" and "Society guideline links: Carpal tunnel syndrome".)

International

●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immune checkpoint inhibitor-related adverse events (2021, updated 2024)

●European Academy of Neurology (EAN)/Peripheral Nerve Society (PNS): Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy, second revision (2021)

●International Workshop on Waldenström's Macroglobulinemia (IWWM): Recommendations for the investigation and management of IgM and Waldenström-associated peripheral neuropathies (2017)

●Toronto Consensus Panel on Diabetic Neuropathy: Cardiovascular autonomic neuropathy in diabetes – Clinical impact, assessment, diagnosis, and management (2011)

●Toronto Consensus Panel on Diabetic Neuropathy: Painful diabetic peripheral neuropathy – Consensus recommendations on diagnosis, assessment and management (2011)

●European Federation of Neurological Societies (EFNS)/PNS: Guideline on management of multifocal motor neuropathy, first revision (2010)

●EFNS/PNS: Guideline on management of paraproteinemic demyelinating neuropathies, first revision (2010)

●EFNS/PNS: Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy (2010)

●PNS: Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy (2010)

Canada

●Diabetes Canada (DC): Clinical practice guidelines on neuropathy (2018)

United States

●American Diabetes Association (ADA): Standards of care in diabetes (2025)

•Retinopathy, neuropathy, and foot care

●American Society of Clinical Oncology (ASCO): Guideline for the prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers (2016, updated 2025)

●American Academy of Neurology (AAN), American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM), and American Academy of Physical Medicine and Rehabilitation (AAPMR): Practice parameter on evaluation of distal symmetric polyneuropathy – Role of laboratory and genetic testing (an evidence-based review) (2009, reaffirmed 2022)

●American College of Radiology (ACR): ACR Appropriateness Criteria on cranial neuropathy (revised 2022)

●AAN: Practice guideline on oral and topical treatment of painful diabetic polyneuropathy, update (2021)

●ACR: ACR Appropriateness Criteria on plexopathy (revised 2021)

●American Society of Anesthesiologists (ASA): Practice advisory for the prevention of perioperative peripheral neuropathies, update (2018)

●Society for Integrative Oncology (SIO): Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment (2017)

Europe

●European Society for Medical Oncology (ESMO): Management of toxicities from immunotherapy – Clinical practice guideline for diagnosis, treatment and follow-up (2022)

●European Academy of Neurology (EAN)/Peripheral Nerve Society (PNS): Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy, second revision (2021)

●ESMO-European Oncology Nursing Society (EONS)-European Association of Neuro-Oncology (EANO): Clinical practice guidelines for diagnosis, prevention, treatment and follow-up of systemic anticancer therapy-induced peripheral and central neurotoxicity (2020)

●European Myeloma Network (EMN): Guidelines for the management of multiple myeloma-related complications (2015)

●European Federation of Neurological Societies (EFNS): Guidelines for the molecular diagnosis of neurogenetic disorders – Motoneuron, peripheral nerve and muscle disorders (2011)

●EFNS/PNS: Guideline on management of multifocal motor neuropathy, first revision (2010)

●EFNS/PNS: Guideline on management of paraproteinemic demyelinating neuropathies, first revision (2010)

●EFNS/PNS: Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy (2010)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Medical technologies guidance on Neuropad for detecting preclinical diabetic peripheral neuropathy (2018, updated 2022)

●British Committee for Standards in Haematology (BCSH): Guidelines on the diagnosis and management of Waldenström macroglobulinaemia (2014)

Japan

●[In Japanese] Japanese Society of Neurology (JSN): Clinical practice guidelines for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy, 2nd edition (2024)

●[In Japanese] Japanese Association of Supportive Care in Cancer (JASCC): Clinical guidelines of management for chemotherapy-induced peripheral neuropathy, 2nd edition (2023)